De novo infection of B cells during murine gammaherpesvirus 68 latency

Michael L Freeman1, Claire E Burkum, Eric J Yager

  • 1Trudeau Institute, 154 Algonquin Avenue, Saranac Lake, NY 12983, USA.

Journal of Virology
|August 19, 2011
PubMed

Insights

Gammaherpesvirus (GHV) latency is controlled by both T cells and antibodies. These immune components prevent the spread of GHV to new B cells, even during viral reactivation.

Area of Science:

  • Virology
  • Immunology
  • Infectious Diseases

Background:

  • Gammaherpesviruses (GHVs) establish lifelong latent infections.
  • The precise mechanisms governing GHV latency maintenance remain largely unknown.

Purpose of the Study:

  • To investigate the role of the immune system in controlling gammaherpesvirus latency and reactivation.
  • To elucidate the mechanisms of viral spread during latent infection.

Main Methods:

  • Utilized a murine gammaherpesvirus (MHV) model in immunocompetent mice.
  • Employed in vivo T cell depletion strategies.
  • Assessed viral loads and viral transfer to naive B cells.

Main Results:

  • Previously uninfected B cells acquired virus during latency in immunocompetent mice.
  • T cell depletion led to viral reactivation but not enhanced viral spread to new cells.
  • Absence of both T cells and antibodies resulted in robust infection of new B cells from latently infected cells.

Conclusions:

  • Both T cells and antibodies are critical for controlling gammaherpesvirus latency.
  • Immune surveillance effectively limits viral reactivation and spread during latent infection.
  • Understanding these mechanisms is key to developing strategies against persistent viral infections.